Easehale 0.025% 2ml RSPLS

Description

Indications

Easehale 0.025% 2ml RSPLS is primarily indicated in conditions like Asthma, Bronchospasm prophylaxis, Chronic obstructive pulmonary disease, Reversible airways obstruction, Rhinorrhea, and can also be given in adjunctive therapy as an alternative drug of choice in Rapid reversion to sinus ryhthm.

Contraindication

Easehale 0.025% 2ml RSPLS is contraindicated in conditions like Glucoma,Prostatic hypertrophy, Hypersensitivity,Urinary retention,Bladder obstruction.

Side Effects

The severe or irreversible adverse effects of Easehale 0.025% 2ml RSPLS, which give rise to further complications include Tachycardia, Palpitation, Angina, Tremors, Arrythmia, Tachycardia. The signs and symptoms that are produced after the acute overdosage of Easehale 0.025% 2ml RSPLS include Palpitations, Increased heart rate.The symptomatic adverse reactions produced by Easehale 0.025% 2ml RSPLS are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Constipation, Dry mouth, Blurred vision, Rashes, Urticaria, Dyspepsia, Nausea and vomiting, Nasal congestion, Backache, Nasal irritation, Urinary RetentionX, Urinary retention, Dry mouth, dizziness, dyspepsia, Anaphylaxia.

 Warnings

Ipratropium should be used with caution in patients with medical history especially of glaucoma, prostate trouble or any allergy especially to atropine or other belladonna derivatives. It should be used with caution during pregnancy.